A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B

NCT05202405 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: AD-221
DRUG: AD-221A and AD-221B

Sponsor

Addpharma Inc.